Observational Study on the Efficacy and Safety of NovoSeven® During "Real-life" Usage in Germany

Clinical trial NCT00697320 · COMPLETED

Trial details

NCT number: NCT00697320
Sponsor: Novo Nordisk A/S
Status: COMPLETED
Study type: OBSERVATIONAL

Congenital Bleeding Disorder Congenital FVII Deficiency Glanzmann's Disease Acquired Bleeding Disorder Acquired Haemophilia

Start date: 2008-06-01
Primary completion: 2010-12-01
Enrollment: 64

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.